Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.445 USD | -1.41% | -0.42% | -15.48% |
05-13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
05-13 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
THERAVANCE BIOPHARMA, INC. | Other Pharmaceuticals | -0.84% | -0.42% | -15.48% | -15.63% | -55.55% | 465M |
Technical Rankings Surperformance
- Stock Market
- Equities
- TBPH Stock
- Charts Theravance Biopharma, Inc.
- Comparison Chart